(Q40869910)

24 September 2017

1 reference

title

Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects (English)

1 reference

24 September 2017

0 references

cytomegaloviral disease

1 reference

Hebart H

1

1 reference

24 September 2017

Kanz L

series ordinal

2

1 reference

24 September 2017

Jahn G

series ordinal

3

1 reference

24 September 2017

Einsele H

series ordinal

4

1 reference

24 September 2017

1 January 1998

1 reference

24 September 2017

1 reference

24 September 2017

55

1 reference

24 September 2017

59-72

1 reference

24 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855010-00005

24 September 2017

0 references

cites work

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

12 December 2020

Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia

1 reference

12 December 2020

Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease

1 reference

12 December 2020

A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients

1 reference

12 December 2020

Absence of association between cytomegalovirus infection and obliterative transplant arteriopathy in renal allograft rejection

1 reference

12 December 2020

Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression

1 reference

12 December 2020

Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation

1 reference

12 December 2020

Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation

1 reference

12 December 2020

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

12 December 2020

Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients

1 reference

12 December 2020

Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods

1 reference

12 December 2020

Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease

1 reference

12 December 2020

The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?

1 reference

12 December 2020

Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant

1 reference

12 December 2020

A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation

1 reference

12 December 2020

Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients

1 reference

12 December 2020

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.

1 reference

12 December 2020

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

12 December 2020

Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation

1 reference

12 December 2020

Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.

1 reference

12 December 2020

Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.

1 reference

12 December 2020

A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation

1 reference

12 December 2020

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

12 December 2020

Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis.

1 reference

12 December 2020

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

12 December 2020

Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation

1 reference

12 December 2020

Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes.

1 reference

12 December 2020

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

1 reference

12 December 2020

Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients

1 reference

12 December 2020

Cytomegalovirus in liver biopsies of marrow transplant recipients: detection methods, clinical, histological and immunohistological features

1 reference

12 December 2020

Long-term prognosis of renal transplantation after preemptive treatment of cytomegalovirus infection

1 reference

12 December 2020

Endocapillary glomerulitis in the renal allograft

1 reference

12 December 2020

Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients

1 reference

12 December 2020

Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients

1 reference

12 December 2020

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

12 December 2020

European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

12 December 2020

Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients

1 reference

12 December 2020

Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation

1 reference

12 December 2020

Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction

1 reference

12 December 2020

Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test

1 reference

12 December 2020

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

12 December 2020

Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

1 reference

12 December 2020

Cytomegalovirus infection complicating renal transplantation and its relationship to acute transplant glomerulopathy

1 reference

12 December 2020

A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant

1 reference

12 December 2020

OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation

1 reference

12 December 2020

Optimization of detection of cytomegalovirus viremia in transplantation recipients by shell vial assay.

1 reference

12 December 2020

Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation

1 reference

12 December 2020

Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation

1 reference

12 December 2020

Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique

1 reference

12 December 2020

Detection of cytomegalovirus DNA in sera of liver transplant recipients.

1 reference

12 December 2020

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

12 December 2020

Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation

1 reference

12 December 2020

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

12 December 2020

Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis

1 reference

12 December 2020

The prognostic significance of positive CMV cultures during surveillance of renal transplant recipients

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia

1 reference

12 December 2020

Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients

1 reference

12 December 2020

Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease

1 reference

12 December 2020

High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients

1 reference

12 December 2020

Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group

1 reference

12 December 2020

Demonstration of cytomegalovirus by polymerase chain reaction after liver transplantation.

1 reference

12 December 2020

Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction.

1 reference

12 December 2020

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Diagnosis of cytomegalovirus (CMV) disease in renal allograft recipients: the role of semiquantitative polymerase chain reaction (PCR).

1 reference

12 December 2020

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

12 December 2020

Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant

1 reference

12 December 2020

Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture

1 reference

12 December 2020

Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients

1 reference

12 December 2020

Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients

1 reference

12 December 2020

A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood

1 reference

12 December 2020

Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens.

1 reference

12 December 2020

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

12 December 2020

Circulating immediate-early mRNA in patients with cytomegalovirus infections after solid organ transplantation

1 reference

12 December 2020

Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

1 reference

12 December 2020

Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

1 reference

12 December 2020

1 reference

12 December 2020

Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy

1 reference

12 December 2020

Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients

1 reference

12 December 2020

Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection

1 reference

12 December 2020

Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction

1 reference

12 December 2020

Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates

1 reference

12 December 2020

Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis

1 reference

12 December 2020

Efficacy of a 6-week prophylactic ganciclovir regimen and the role of serial cytomegalovirus antibody testing in lung transplant recipients

1 reference

12 December 2020

Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients

1 reference

12 December 2020

Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro

1 reference

12 December 2020

Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients

1 reference

12 December 2020

Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients

1 reference

12 December 2020

Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo

1 reference

12 December 2020

The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection

1 reference

12 December 2020

Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir

1 reference

12 December 2020

How effective is oral ganciclovir?

1 reference

12 December 2020

Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.

1 reference

12 December 2020

Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart

1 reference

12 December 2020

Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay.

1 reference

12 December 2020

Removal of cytomegalovirus DNA from donor blood by filtration

1 reference

12 December 2020

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

1 reference

12 December 2020

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

1 reference

12 December 2020

Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants

1 reference

12 December 2020

Evaluation of the Digene Hybrid Capture System for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation

1 reference

12 December 2020

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

12 December 2020

Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients

1 reference

12 December 2020

Incidence of local CMV infection and acute intestinal GVHD in marrow transplant recipients with severe diarrhoea

1 reference

12 December 2020

Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma

1 reference

12 December 2020

Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation

1 reference

12 December 2020

Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment

1 reference

12 December 2020

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

1 reference

12 December 2020

Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients

1 reference

12 December 2020

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

12 December 2020

Demonstration of cytomegalovirus after bone marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes.

1 reference

12 December 2020

Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.

1 reference

12 December 2020

10.2165/00003495-199855010-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference